Aesthetic Medicine Market Size, Share and Trends Analysis, By Product Type (Facial Aesthetic Products, Cosmetics Implants, Skin Aesthetic Devices, Body Contouring Devices, and Others), By Type of Device (Standalone Device, Multimodal Device, and At Home/Self Use Device), By Application (Surgical and Non-Surgical), By End-Use, and By Region, Forecast 2025-2032

Aesthetic Medicine Market Overview and Key Insights:

The aesthetic medicine market size reached USD 29.77 billion in 2024 and is expected to register a revenue CAGR of 9.8% during the forecast period. Aesthetic medicine encompasses any medical operations used to improve a patient’s physical appearance and happiness, ranging from non-invasive to minimally invasive cosmetic procedures. Several medical diseases are currently being treated using products, techniques, or technology that were formerly employed for aesthetic purposes.

Market Drivers:

Rising consumer demand for minimally invasive cosmetic procedures is a key driver of revenue growth in the aesthetic medicine market. According to the American Society of Plastic Surgeons (ASPS), minimally invasive procedures increased 7% in 2023, outpacing surgical treatments by 2%.  Neuromodulator injections and hyaluronic acid fillers continued to increase, with almost 9 million and 5 million procedures, respectively. Advancements in technology and patients’ preference for cost-effective procedures, subtle outcomes, and short recovery times have fuelled the continuous interest.

Chemical peels remained a popular option for skin rejuvenation, with over 1 million treatments performed, representing an 8% rise. In addition, laser hair removal operations increased by 9% to more than 800,000, demonstrating a growing preference for long-term hair reduction methods. Laser skin resurfacing also gained traction, with over 1 million operations conducted, representing a 4% increase over the previous year. Other facial operations, such as eyelid surgery and nose contouring, grew in popularity by 5% and 6%, respectively. The continued interest in eyelid surgery may reflect a shift toward less invasive treatments performed under local anaesthetic.

On March 2025, Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, announced the global launch of Alma Harmony, an aesthetics platform. The new evolution is powered by five of the most popular technologies, brilliantly integrated to provide a comprehensive range of treatments for almost any indication or skin type: Q-Switch Laser, Fractional Ablative Laser, Intense Pulsed Light (IPL), Non-Ablative Lasers, and Green Diode Laser.

Market Opportunity:

Expanding medical tourism for affordable cosmetic procedures act as an opportunity for aesthetic medicine market. Cosmetic procedures are among the most popular destination surgeries, and they often include abdominoplasty, breast augmentation, gluteal augmentation, and liposuction. Cosmetic procedures in developed countries are expensive. These treatments can be obtained conveniently in other nations for around one-third the cost while enjoying a wonderful holiday. Asia Pacific and Middle Eastern countries have a very high potential for the future dermal filler. Tourists from affluent countries choose these countries for anti-aging treatments while on holiday.

Statistics show that approximately 1.3 million health travellers visit Mexico each year, drawn by savings of 40-60% compared to prices in the United States. Similarly, Malaysia’s healthcare scene is bolstered by JCI-accredited institutions that cater to both local and international patients, cementing the country’s position as a top destination for aesthetic upgrades. This development represents a broader shift in how people perceive healthcare, with many viewings it as an essential component of a health-conscious lifestyle.

Recent Trends:

Emerging trends include neurotoxin injections, chemical peels, microdermabrasion, cellulite treatment, body contouring procedures, and cryolipolysis and cavitation lipolysis.

According to American Academy of Dermatology Association, acne is the most common skin problem in the United States, impacting an estimated 50 million people each year.  Approximately 85% of people between the ages of 12 and 24 have mild acne. Acne normally starts in puberty and affects many teenagers and young adults; however, it can appear at any age and can last into one’s 30s and 40s. Adult acne continues to rise, affecting up to 15% of women. Acne vulgaris affects urban people more than rural populations. Approximately 20% of those impacted have severe acne, which leaves scarring. According to some data, the severity and prevalence of acne vulgaris may vary among different racial and ethnic groups.

On January 2025, Lipoid Kosmetik developed Peeling Complex, a novel substance that combines citric acid (AHA), gluconic acid (PHA), and amber acid (DCA) in a well-balanced, ready-to-use formulation. This potent mix provides balanced exfoliating actions that deliver both instant and long-term results across all skin layers. Additional in vivo investigations have validated the exfoliation efficacy and consumer satisfaction in both leave-on and rinse-off formulations. With its broad application range and balanced exfoliation strength, it fully satisfies the expectations of current sophisticated consumers.

Restraints & Challenges:

Aesthetic medicine poses few hazards; however, treatments must be performed by trained and skilled aestheticians. Complications might occur because of inadequate post-operation care, the incorrect device selection, the specific patient’s response to treatment, or even an inaccurate treatment approach. Aesthetic surgeons may receive consumer complaints because of expected or unexpected consequences. Patients frequently experience injection-related bruises, burning sensations, inflammation, allergies, rashes, and other side effects.

While treating and reconstructing the aesthetic appearance of a deformity acquired because of a car accident, fire incident, etc., is considered normal and socially acceptable, aesthetics performed to assist a patient in achieving a celebrity-type similar look is ethically challenged by both the public and medical community. The ethical side of medical aesthetics is very subjective, and an aesthetician may find it challenging to deal with.

Product Type Segment Insights and Analysis:

Based on the product type, the aesthetic medicine market is segmented into facial aesthetic products, cosmetics implants, skin aesthetic devices, body contouring devices, hair removal devices, and others.

Facial aesthetic products segment contributed the highest market share in 2024. It is further sub segmented into botulinum toxin, dermal fillers, microdermabrasion products, and chemicals peels. Facial aesthetic treatments provide numerous possibilities for improving and revitalizing facial features. Neuromodulators, such as Botulinum Toxin, are injectable medicines that temporarily inhibit nerve signals to the muscles, lowering muscle activity and relaxing the treated area. They offer a non-surgical option for reducing indications of aging with minimal downtime and pain. Neuromodulators can also be used preventatively in younger individuals to delay the appearance of wrinkles.

On April 2025, AbbVie has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) to treat moderate to severe glabellar lines. TrenibotE will be the first serotype E neurotoxic, allowing patients to experience a neurotoxin with a quick clinical effect for a shorter period as a trial before receiving BOTOX Cosmetic.

Type of Device Segment Insights and Analysis:

Based on the type of device, the aesthetic medicine market is segmented into standalone device, multimodal device, and at home/self-use device.

Standalone device segment contributed the largest market share in 2024. Stand-alone systems are often constructed with only one hand piece (HP) that emits a single wavelength. They are intended for specialized objectives, such as hair reduction or tattoo removal. These devices typically treat a small set of indications. That is one of the reasons they are more popular among experienced physicians with established practices. They are ideal for major spas or clinics with big budgets.

On March 2025, Candela Corporation, headquartered in Marlborough, MA, has announced the global launch of the Glacē solution. Glacē is the only skin purification treatment that incorporates dual-mode cupping massage, delivering two modes: one for lymphatic drainage and natural detoxification, and another for a temporary sculpted effect. Its two-phase serum system is adaptable and provides specific treatments for a variety of skin types and issues, such as acne, sensitivity, dryness, uneven tone, and aging.

Furthermore, on October 2024, Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, has launched Mosaic 3D, a 1550 nm Erbium Glass non-ablative fractional resurfacing laser, on the sixth month anniversary of its merger. The Mosaic 3D platform is intended to drastically address patients’ tone and texture concerns by producing superficial and mid-dermal coagulation. Mosaic 3D is a highly adaptable stand-alone platform that enables clinicians to tailor patient treatments for optimal effectiveness while regulating patient comfort and reducing downtime with integrated air cooling.

Application Segment Insights and Analysis:

Based on the application, the aesthetic medicine market is segmented into surgical procedure and non-surgical procedure.

Surgical procedure segment contributed the largest market share in 2024. It is further segmented into breast augmentation, rhinoplasty, facelift and body, and others. The most common cosmetic plastic surgery technique is breast augmentation. In 2022, around 300,000 breast augmentation surgeries were carried out by ASPS Member Surgeons. More than 54.6% of women who receive breast augmentations are in the 18–34 age range, and 35.6% are in the 35–50 age range. Approximately 98% of women are happy with the outcomes of their breast augmentation, according to studies. Following the surgery, these ladies report notable improvements in their quality of life and self-esteem, with 64% mentioning an improved quality of life and 92% reporting a rise in self-esteem.

On May 2025, Johnson & Johnson MedTech, a global leader in breast aesthetics and reconstruction, has announced the U.S. introduction of MENTOR MemoryGel Enhance Breast Implants, which fills a vital need in comprehensive breast cancer care for mastectomy patients. The FDA-approved MENTOR MemoryGel Enhance Breast Implants are the first and only implant line designed particularly for women with larger breasts, with sizes ranging from 930 cc to 1445 cc.

Geographical Outlook:

Aesthetic medicine market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamic. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different region and countries.

North America Aesthetic Medicine Market:

North America is registered to have highest market share in aesthetic medicine market in 2024. This is mainly driven by rising consumer demand for minimally invasive cosmetic procedures and technological advancements in lasers, injectables, and skin rejuvenation. Plastic surgery is seeing rapid development, with an estimated 35 million cosmetic treatments performed worldwide in 2023, a 3.4% increase over the previous year. In the United States alone, approximately 6.2 million cosmetic treatments were registered, indicating that the market is continuing to grow. Specific treatments show that liposuction has remained the most popular surgical option, accounting for 347,782 procedures, up 7% since 2022.

Botulinum toxin injections are the most popular non-surgical treatment, with over 9.4 million operations performed, indicating a high preference for minimally invasive methods. The average cost of aesthetic operations has increased slightly, although patient satisfaction remains high. For example, the typical cost of a stomach tuck is around USD 7,500, although 95% of patients are satisfied with their results. This enjoyment serves to drive demand, as pleasant experiences pique interest in other aesthetic procedures.

On June 2025, Allergan Aesthetics, an AbbVie business, stated that the US Food and Drug Administration (FDA) has accepted for evaluation the supplemental premarket approval (sPMA) application for JUVÉDERM’s SKINVIVE to minimize neck wrinkles and improve neck look. SKINVIVE by JUVÉDERM is currently approved in the United States to improve skin smoothness in the cheeks in individuals over the age of 21. SKINVIVE by JUVÉDERM is an injectable form of hyaluronic acid, a naturally occurring chemical present in the skin that is essential for skin hydration.

Asia Pacific Aesthetic Medicine Market:

Asia Pacific is expected to register the fastest growth rate during the forecasted period, augmented by technological advancements in lasers, injectables, and skin rejuvenation and growth in non-invasive and combination therapies. Furthermore, expanding medical tourism for affordable cosmetic procedures is also driving the market growth in the region. Technological advancements are dramatically revolutionizing aesthetic medicine in India, with Artificial Intelligence (AI) improving personalized treatment planning. Minimally invasive techniques, such as advanced Platelet-Rich Plasma (PRP) therapies and radiofrequency microneedling, are becoming increasingly popular due to their effectiveness and short recovery times. Regenerative medicine techniques, such as stem cell and exosome therapy, are also emerging as promising alternatives.

On August 2025, Primelaze, a Puducherry-based business, has worked with German dermatological laser pioneer Hypertech Laser Systems (HLS) to deliver innovative BiAxis QS & BiAxis Pico – Q-Switched Nd:YAG technology, a ground-breaking advancement in the field of cosmetic and medical dermatology. This cutting-edge laser system has innovative features designed to improve treatment efficacy and safety for dermatological applications. Q-Switched Nd:YAG Technology is intended to accommodate all skin types and allow for a wide range of treatments.

Europe Aesthetic Medicine Market:

Europe is expected to have considerable market share in 2024, driven by rising consumer demand for minimally invasive cosmetic procedures, technological advancements in lasers, injectables, and skin rejuvenation, and growth in non-invasive and combination therapies. Germany, France, Austria, Spain, Switzerland, Belgium, Italy, and Greece are Western Europe’s leaders, providing convenient access to high-end medicine and cutting-edge facilities at reasonable costs. Eastern Europe’s appeal stems from the cheaper cost of typical medical, surgical, and dental operations, with Hungary, the Czech Republic, and Poland leading the way.

On February 2025, CollPlant Biotechnologies, a regenerative and aesthetic medicine firm creating breakthrough technologies, has announced the expansion of distribution channels for its Vergenix STR product across Europe and Asia. VergenixSTR is based on the Company’s rhCollagen technology and is designed to treat tendinopathy by facilitating healing and repair of tendon injuries in a number of tendons, including the elbow, rotator cuffs, patellar tendons, Achilles tendon, and hand tendons.

Competition Analysis:

The aesthetic medicine market is characterized by a fragmented structure, with several players competing across various segments and regions. list of major players included in the aesthetic medicine market report are:

• Allergan Aesthetics
• Merz Pharma
• Sinclair
• Candela Corporation
• Alma Lasers
• Galderma SA
• Cutera, Inc.
• Cynosure Lutronic
• Lumenis Be Ltd
• Evolus, Inc.
• Solta Medical
• Revance Therapeutics, Inc.
• Sisram Medical Ltd
• Sientra, Inc.
• Skin Tech Pharma Group

Strategic Developments in Aesthetic Medicine Market:

• In April 2025, Galderma has announced the launch of Sculptra in China, the first proven regenerative biostimulator with a unique poly-L-lactic acid formulation. This launch demonstrates Galderma’s dedication to expanding its unrivaled aesthetics range into new geographies to better serve patients and healthcare professionals. This launch further expands Sculptra’s global reach, which already spans over 40 countries and regions worldwide.
• In June 2025, KYLYS AESTHETICS SA, a Geneva-based biotech business focused on regenerative aesthetic solutions, has completed a CHF 1 million fundraising round to support the development and clinical validation of its primary medical device. FONGIT, The Berlin Angel Fund, Business Angel Club Berlin-Brandenburg, as well as other private and strategic investors, have all contributed to the round. KYLYS, a spin-off from the University of Geneva, was founded in 2023 and is developing Class III medical devices and cosmeceutical goods using patented hyaluronic acid (HA) technology.
• In January 2025, Ascend Plastic Surgery Partners announced its latest collaboration with Ponte Vedra Plastic Surgery (PVPS), a well-known institution in the field of plastic and cosmetic surgery. This collaboration advances Ascend’s aim of raising patient care standards and providing exceptional cosmetic services throughout the United States. PVPS expands Ascend’s presence into Florida, adding a fifth state, six more surgeons, and six new locations to its network.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights Of The Aesthetic Medicine Market Report:

The Aesthetic Medicine market report offers a detailed analysis of market size, including historical revenue (in USD Billion) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Product Type Outlook (Revenue, USD Billion; 2022-2032)
  • Facial Aesthetic Products
    • Botulinum Toxin
    • Dermal Fillers
    • Microdermabrasion Products
    • Chemicals Peels
  • Cosmetics Implants
    • Breast Implants
    • Gluteal Implants
    • Facial Implants
  • Skin Aesthetic Devices
    • Nonsurgical Skin Tightening Devices
    • Laser Skin Resurfacing Devices
    • Micro Needling Products
    • Light Therapy Devices
  • Body Contouring Devices
    • Nonsurgical Fat Reduction Devices
    • Cellulite Reduction Devices
    • Liposuctions Devices
  • Hair Removal Devices
    • Laser Hair Removal Devices
    • Intense Pulse Light Hair Removal Devices
  • Others

• Type of Device Outlook (Revenue, USD Billion; 2022-2032)
  • Standalone Device
  • Multimodal Device
  • At Home/Self Use Device

• Application Outlook (Revenue, USD Billion; 2022-2032)
  • Surgical Procedure
    • Breast Augmentation
    • Rhinoplasty
    • Facelift and Body
    • Others
  • Non-Surgical Procedure
    • Anti-Aging and Skin Rejuvenation
    • Tattoo and Scar Removal
    • Hair Removal
    • Lypolysis
    • Others

• End-Use Outlook (Revenue, USD Billion; 2022-2032)
  • Hospitals
  • Dermatology Clinics
  • Medical Spas and beauty spa
  • Home Settings

• Regional Outlook (Revenue, USD Billion; 2022-2032)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) about the Aesthetic Medicine market report